France-based ArchiMed, a healthcare-focused private equity firm, have hired Benoît Adelus and André-Michel Ballester as partners. Adelus was the chairman and CEO of Sebia while Ballester is currently chairman of ArchiMed portfolio company Citieffe. PRESS RELEASE February 12, 2018 – Benoît Adelus and André-Michel Ballester are joining the senior management of European private equity healthcare…
Marseille, April 23, 2018 – Provepharm Life Solutions announces today that ArchiMed and Téthys Invest have joined the company’s shareholder base as minority investors. Both are renowned investors with strong expertise in the healthcare sector. Beyond financial considerations, it was the specific support for the company’s long-term growth project and the entrepreneurial track record of its…
Citieffe, a European company focused on Extremities and Trauma (Orthopaedics) implants, is delighted to announce the first clinical case of its Distal Radius (Wrist) Plate. This innovative and patented plating system is the newest addition to Citieffe’s growing portfolio in Extremities. Citieffe announced the launch of the distal radius plate earlier in 2017 during the…
ArchiMed raises €315m for second fund Published: 18 September 2017 By: Rod James The healthcare-focused firm, run by former 3i executives, completed fundraising in four months. ArchiMed, a healthcare-focused private equity firm, has hit the €315 million hard-cap on its second fund, Private Equity International has learned. Med II took four months to raise and…
ACTUS Archimed atteint son hard cap à 315 millions d’euros pour son fonds 2 19.09.17 – Benoît PELEGRIN Il a seulement fallu trois mois et demi à Denis Ribon, président d’Archimed, et son équipe pour boucler la levée du deuxième millésime d’Archimed. Le fonds d’investissement fondé en 2014 par l’ancien responsable de la Santé chez…
Les Confidentiels de CFNEWS 18 septembre 2017 407 mots Par Anne Joly ArchiMed atteint le hard cap pour son fonds II Le capital investisseur européen basé à Lyon et dédié à la santé vient de boucler son deuxième fonds, Med II, en réunissant 315 M€. Trois ans après avoir levé 150 M€ pour son premier fonds dédié…
To receive ArchiMed News, please complete the form below.